Should poor risk patients with Hodgkin's disease be sorted out for intensive treatments?
about
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio LinfomiTreatment results in advanced stage Hodgkin's lymphoma: a retrospective study.Comparison of prognostic models in patients with advanced Hodgkin disease. Promising results from integration of the best three systems.
P2860
Should poor risk patients with Hodgkin's disease be sorted out for intensive treatments?
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Should poor risk patients with Hodgkin's disease be sorted out for intensive treatments?
@en
type
label
Should poor risk patients with Hodgkin's disease be sorted out for intensive treatments?
@en
prefLabel
Should poor risk patients with Hodgkin's disease be sorted out for intensive treatments?
@en
P2860
P1433
P1476
Should poor risk patients with Hodgkin's disease be sorted out for intensive treatments?
@en
P2093
P2860
P356
10.3109/10428199509052703
P478
15 Suppl 1
P577
1995-01-01T00:00:00Z